In the past trade week, numerous experts have once again gained the exit from shares. These shares were recommended for sale by the analysts.
– on your own behalf –
Tip: Act your shares now for € 0.00 At finanzen.net zero! Inform here
16th place: the ranking
Investors who want to buy or sell shares often consult analysts. In the past trade week, numerous experts have once again gained the exit from shares. These shares were recommended for sale by the analysts.
Source: finanzen.net, Image: Maxx-Studio / Shutterstock.com
15th place: Unilever
The major Swiss bank UBS left the classification for Unilever with a price target of 4050 pence on “Sell”. For analysis
Source: finanzen.net, Image: Ohn Thys/AFP/Getty Images
14th place: Zalando
The US analysis house Bernstein Research left the classification for Zalando with a price target of 19 euros on “Under Perperform”. For analysis
Source: finanzen.net, Image: Nitpicker / Shutterstock.com
13th place: Nordea
The US bank JPmorgan left Nordea on “Underweight” with a price target of 120 Swedish crowns. For analysis
Source: finanzen.net, Image: Vytauta’s Kielaitis / Shutterstock.com
12th place: Fraport
Deutsche Bank Research left the classification for Fraport with a price target of 40 euros on “Sell”. For analysis
Source: finanzen.net, Image: Vytauta’s Kielaitis / Shutterstock.com
11th place: Diageo
The US investment bank Goldman Sachs has left the classification for Diageo on “Sell” with a price target of 2400 pence. For analysis
Source: finanzen.net, Image: Carl Court/AFP via Getty Images
10th place: Roche
Deutsche Bank Research raised the price target for Roche from CHF 250 to CHF 265 and left the classification on “Sell”. For analysis
Source: finanzen.net, Image: Roche
9th place: Lanxess
The US bank JPmorgan left the classification for Lanxess according to the outlook of the US group FMC Corp with a price target of 23 euros on “Underweight”. For analysis
Source: finanzen.net, Image: Lanxess
8th place: Novo Nordisk
The Jefferies analysis house left the classification for Novo Nordisk with a price target of 515 Danish crowns on “Under Perperform”. For analysis
Source: finanzen.net, Image: Jhvephoto / Shutterstock.com
7th place: GSK
The US bank JPmorgan left the classification for GSK with a price target from 1440 pence on “Underweight”. For analysis
Source: finanzen.net, Image: PD
6th place: rational
The Baader Bank rationally left “Reduce” with a price target of 720 euros after preliminary quarterly figures. For analysis
Source: finanzen.net, picture: rational
5th place: Intel
DZ Bank has reduced the fair value for Intel on the occasion of the recently presented quarterly figures from $ 20 to $ 18 and left the classification to “sell”. For analysis
Source: finanzen.net, picture: lyao / shutterstock.com
4th place: metro
Baader Bank left the classification for Metro AG to “Reduce” with a price target of 4 euros. For analysis
Source: finanzen.net, Image: Metro AG
3rd place: under Armor
The US bank JPmorgan has reduced the price target for Under Armor after quarterly figures from $ 8 to $ 7 and left the classification on “Underweight”. For analysis
Source: finanzen.net, Image: Raymond Boyd/Getty Images
2nd place: Docmorris
The major Swiss bank UBS stamped the price target for DocMorris from CHF 25 to CHF 16 and left the classification on “Sell”. For analysis
Source: finanzen.net, Image: Ralf Liebhold / Shutterstock.com
1st place: l´oréal
The US bank JPmorgan left the classification for L’Oréal on “Underweight” with a price target of 290 euros. For analysis
Source: finanzen.net, Image: Arseniy Krasnevsky / Shutterstock.com